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Abstract
Objective Follicular granulocyte colony-stimulating factor (G-CSF) is a new biomarker of oocyte quality and embryo implan-
tation in in vitro fertilization (IVF) cycles. Its role in reproduction is poorly understood. Our study aimed to investigate the
mechanisms and cells responsible for G-CSF production in the preovulatory follicle.
Design Laboratory research study.
Setting Single-center study.
Interventions Granulosa cells and leukocytes were isolated from the follicular fluids (FF) or the blood of women undergoing IVF
and from the blood of a control group of women with spontaneous ovulatory cycles to perform cocultures.
Main outcome measure G-CSF-secreted protein was quantified in the conditioned media of cocultures.
Results G-CSF secretion was considerably increased in cocultures of granulosa cells and leukocytes. This effect was maximal
when leukocytes were isolated from the blood of women in the late follicular phase of the menstrual cycle or from the FF of
women undergoing IVF. The leukocyte population isolated from the FF samples of women undergoing IVF had a higher
proportion of granulocytes than that isolated from the corresponding blood samples. Leukocytes induced the synthesis and
secretion of G-CSF by granulosa cells. Among a range of other FF cytokines/chemokines, only growth-regulated oncogene
alpha (GROα) was also increased.
Conclusion The notable rise in G-CSF at the time of ovulation coincides with the accumulation of follicular granulocytes, which
stimulate G-CSF production by granulosa cells via paracrine interactions. High follicular G-CSF concentrations may occur in
follicles with optimal granulosa–leukocyte interactions, which could explain the increased implantation rate of embryos arising
from these follicles.
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Introduction
Follicular fluid (FF) surrounds the oocyte and constitutes the
milieu in which signaling molecules circulate between granulosa
cells and the oocyte during folliculogenesis and oocyte matura-
tion [1]. FFs are collected with the oocytes during in vitro fertil-
ization (IVF) procedures and are discarded after oocyte retrieval.
Therefore, FF represents a source of non-invasive biomarkers of
oocyte quality. A competent oocyte is able to be fertilized and to
support the first steps of embryo development [2]; however, only
30% of retrieved oocytes will develop into a good quality em-
bryo and 5% will result in a live birth [3, 4]. Oocyte quality
assessment remains a challenge in IVF, since morphology is
poorly predictive of oocyte competence [5].
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Ovulation has been compared to a controlled inflammatory
reaction with local hyperemia, connective tissue degradation,
chemokine/cytokine accumulation, and leukocyte chemotaxis
in the preovulatory follicle [6–9]. G-CSF is a multifunctional
cytokine, best known for stimulating the production and dif-
ferentiation of neutrophils during hematopoiesis and promot-
ing their activation, with key roles in immunity and inflam-
matory responses [10–12]. G-CSF also has a recognized role
in several aspects of human reproduction [13–16]. In a recent
trial with an ultra-sensitive ELISA specifically designed for
the quantification of follicular G-CSF, the probability of suc-
cessful implantation was 3.3-fold higher for embryos derived
from follicles with high G-CSF levels than for those derived
from follicles with low G-CSF levels [17].
However, the mechanisms and role of follicular G-CSF in
oocyte maturation and ovulation remains poorly understood,
including the understanding of fundamental aspects regarding
the local production and secretion of G-CSF. Serum G-CSF
level peaks at the time of spontaneous ovulation [18] or ovu-
lation induction during ovarian stimulation with gonadotro-
phins [19, 20]. The intrafollicular G-CSF production by gran-
ulosa cells and its higher concentration in FF than in serum
[21] suggest that G-CSFmight play a paracrine role within the
follicular environment. It has been demonstrated that human
leukocytes, and in particular neutrophils, accumulate in the
follicular wall just before ovulation [9, 22]. These data suggest
that G-CSF, with its ability to recruit and activate neutrophils,
might play a role in the mechanism of oocyte maturation and
subsequent ovulation.
We were therefore interested in further evaluating the para-
crine interaction between granulosa cells and leukocytes to
enhance preovulatory G-CSF synthesis and secretion.
Materials and methods
Study design
This was a single-center laboratory research study (Centre de
Procréation Médicalement Assistée, CHR Liege Hospital,
Liege University). It was approved by the hospital Ethics
committee (CE412/1508). We used an in vitro system to test
the mechanisms of follicular G-CSF production by granulosa
cells and their paracrine interaction with leukocytes. CD45-
negative human granulosa cells (hGC) and CD45-positive
follicular (fCD45) leukocytes were isolated from the FF of
women undergoing IVF, and CD45-positive blood (bCD45)
leukocytes were isolated from their peripheral blood (Fig. 1a
and b). Blood leukocytes (bCD45) were also isolated from the
peripheral blood of women with spontaneous ovulatory cycles
(Fig. 1a and c). A human granulosa-derived cell line (HGL5)
was also used as a model for primary hGC. The HGL5 cell
line maintains many of the functions of primary hGC [23],
including G-CSF production.
Secreted levels of G-CSF (and a variety of other cytokines
and chemokines) in the conditioned media were analyzed by
ELISA assays following separate cultures (hGC, HGL5,
fCD45, or bCD45 cells); cocultures with cell contact (hGC/
CD45 or HGL5/CD45); and cocultures without cell contact
(hGC(CD45) or HGL5(CD45)). We also assessed the leuko-
cyte subtypes in the populations of fCD45 and bCD45 cells
isolated from women undergoing IVF and the cellular source
of G-CSF production in cocultures of HGL5 cells and leuko-
cytes. Finally, cocultures of HGL5 with bCD45 cells were
performed to evaluate the influence of the menstrual cycle
phase on G-CSF secretion. G-CSF mRNA quantification
was further performed on cell culture assays using the
HGL5 cell line.
Patients
Samples of FF were obtained from 41 women aged 23–
39 years who underwent IVF/ICSI for primary infertility due
to male factor or polycystic ovary syndrome (PCOS) or unex-
plained infertility following hormonal blood tests, ultrasound
examination and sperm analysis (Fig. 1b). All patients
underwent an antagonist protocol for ovarian stimulation. FF
was collected from each of the women to perform 41 indepen-
dent cell isolations. Peripheral blood samples were also col-
lected from 14 of these women at the time of oocyte pick up
(Fig. 1b). In addition, 15 blood samples from 3 women with
spontaneous ovulatory and regular menstrual cycles (27 to
35 days) were collected during the follicular, late follicular,
ovulatory, or luteal phases of one menstrual cycle, based on
the serum levels of estradiol, luteinizing hormone, and proges-
terone (Fig. 1c and Table S1). Seven additional blood samples
were obtained from these women with spontaneous ovulatory
cycles, at various stages of their menstrual cycles. Written
informed consent was obtained from all women included in
the study.
Granulosa cell and leukocyte isolation from follicular
fluids
The protocol of human granulosa cells (hGC) and leukocyte
isolation from FF was adapted from Shi et al. [24], as de-
scribed previously by our team [25]. Briefly, FF was centri-
fuged after oocyte recovery. After the supernatant was re-
moved, the pellet was resuspended in an enzymatic solution
to digest clusters of cells. FF-derived cells (FFDC) were ob-
tained by density gradient centrifugation over Ficoll-Paque
Plus (GE Healthcare, Little Chalfont, Buckinghamshire,
England). Viable cells were counted using the trypan blue
exclusion method.
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Fig. 1 Study design. CD45-negative human granulosa cells (hGC) and
follicular CD45-positive (fCD45) leukocytes were isolated from the FF of
women undergoing ovarian stimulation for IVF, and blood CD45-
positive (bCD45) leukocytes were isolated from their peripheral blood
at the time of oocyte retrieval (a and b). bCD45 leukocytes were also
isolated from the peripheral blood of women with spontaneous ovulatory
cycles (a and c). HGL5 cells correspond to a human granulosa-derived
cell line. Several culture experiments were performed: separate cultures
(hGC, HGL5, fCD45, or bCD45); cocultures with cell contact (hGC/
CD45 or HGL5/CD45) and cocultures without cell contact
(hGC(CD45) or HGL5(CD45)), which were evaluated for secreted G-
CSF by ELISA assay (b and c). G-CSFmRNA quantification was further
performed on cell culture assays using the HGL5 cell line (b and c).
hGC +CD45 and HGL5 + CD45 represent the algebraic sum of G-CSF
secreted by separately cultured hGC and CD45 cells or by separately
cultured HGL5 and CD45 cells (b and c)
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Magnetic-activated cell sorting (MACS) was performed to
obtain the following two cell populations: CD45-negative
cells representing human granulosa cells (hGC) and CD45-
positive cells representing follicular leukocytes (fCD45).
Flow cytometry with a FACSCanto II device (BD
Biosciences) was performed to analyze cell populations. The
median proportions of fCD45 cells and CD45-negative hGC
in the FFDC population were 31% (P25 = 18; P75 = 53) and
69% (P25 = 47; P75 = 82), respectively. hGC cells were con-
taminated with fCD45 cells at a proportion of 2% (median
proportion of hGC cells = 98.0% (P25 = 97.8; P75 = 99.0)),
and fCD45 cells were contaminated with CD45-negative cells
at a proportion of 14.5% (median proportion of fCD45 cells =
85.5% (P25 = 79; P75 = 89.2)). Cell viability was confirmed
by flow cytometry using propidium iodide (Miltenyi Biotec).
Peripheral blood mononuclear cell isolation
Peripheral blood samples were collected in EDTA tubes.
Blood (5 ml) was layered on 5 ml of Ficoll-Paque Plus before
centrifugation at 500gfor 20 min. The superficial phase of the
plasma was removed. The interphase containing peripheral
blood mononuclear cell (PBMC) was collected and washed
twice with phosphate-buffered saline (PBS). Viable cells were
counted using trypan blue exclusion. Then, MACS of PBMC
was performed, following the procedure described for FFDC
[25]. A population of CD45-positive cells called blood leuko-
cytes (bCD45) was obtained, following the protocol described
previously.
Cell culture reagents
FFDC, hGC, follicular and blood leukocytes (fCD45 and
bCD45), and the human granulosa-derived cell line HGL5
[26] were maintained in Dulbecco’s-modified Eagle’s
medium/F-12 with GlutaMAX, supplemented with 10%
heat-inactivated fetal bovine serum and 1% penicillin–
streptomycin (100 IU/ml penicillin and 100 μg/ml streptomy-
cin). In addition, the medium for FFDC and hGC was supple-
mented with 1% ITS (6.25 μg/ml insulin, 6.25 μg/ml trans-
ferrin and 6.25 μg/ml selenium). Culture reagents were all
purchased from Gibco (Thermo Fisher Scientific, Waltham,
MA, USA). Cells were cultured in a traditional humidified
incubator supplied with room air (20% oxygen and 75% ni-
trogen) buffered with 5% CO2 and set to 37 °C.
Cell culture assays
To assess the interaction between granulosa cells (HGL5 cells
or hGC) and leukocytes (fCD45 or bCD45 cells) in terms of
G-CSF production, cells were either cultured separately or
cocultured for 48 h. fCD45 and bCD45 cells were isolated
from the FF or the peripheral blood of women undergoing
IVF. For separate cultures, HGL5 cells or hGC or fCD45 or
bCD45 cells were seeded in 12-well plates at a density of 5 ×
105 cells per well. For cocultures, 5 × 105 HGL5 cells (or
hGC) were seeded with 5 × 105 fCD45 or bCD45 cells per
well. Cocultures of HGL5 (or hGC) and fCD45 without cell
contact were also performed by using plate inserts with a
0.4 mm pore size (ThinCert, Greiner Bio-One, Vilvoorde,
Belgium); 5 × 105 HGL5 (or hGC) cells were seeded into
the bottom chamber and 5 × 105 fCD45 cells were seeded into
the upper chamber. In each experiment, hGC cells were
cocultured with fCD45 or bCD45 cells isolated from the same
woman. After 48 h, conditioned media were collected for the
assessment of G-CSF secretion by ELISA assays and total
RNA was extracted from the cultured cells to determine the
mRNA levels.
To assess the source of G-CSF secretion, cocultures of
HGL5 and fCD45 cells were performed with monensin.
HGL5 and fCD45 cells were individually exposed to
monensin (2 μM, Invitrogen, Thermo Fisher Scientific) over-
night. Control HGL5 and control fCD45 cells, i.e., cells that
were isolated from the FF of the same woman, were not ex-
posed to monensin. Then, the media were removed, the cells
were washed with fresh medium, and the following 4 cocul-
tures of 5 × 105 HGL5 and 5 × 105 fCD45 cells were incubat-
ed for 8 h in 12-well plates: the untreated control coculture
with no previous exposure to monensin; the coculture with
both cell types pretreated with monensin; the coculture with
monensin-pretreated HGL5 cells and untreated control fCD45
cells; and the coculture of untreated control HGL5 and
monensin-pretreated fCD45. After 8 h, conditioned media
were collected for the assessment of G-CSF secretion.
To further evaluate the source of G-CSF secretion, cocul-
tures of HGL5 and bCD45 cells from women with spontane-
ous ovulatory cycles were performed for 24 h with different
proportions of each cell type in 12-well plates: 2.5 × 105
HGL5 cells and 7.5 × 105 bCD45 cells; 5 × 105 HGL5 cells
and 5 × 105 bCD45 cells; or 7.5 × 105 HGL5 cells and 2.5 ×
105 bCD45 cells. After 24 h, conditioned media were collect-
ed for the assessment of G-CSF secretion and total RNAwas
extracted from the cultured cells.
To assess the effect of the menstrual cycle on G-CSF se-
cretion, coculture experiments were performed with HGL5
and bCD45 cells isolated from the peripheral blood of women
with spontaneous ovulatory cycles, at the follicular, late fol-
licular, ovulatory, or luteal phases of one menstrual cycle. A
total of 5 × 105 HGL5 cells and 5 × 105 bCD45 cells were
either cultured separately or cocultured for 48 h in 12-well
plates. After 48 h, conditioned media were collected for the
assessment of G-CSF secretion and total RNAwas extracted
from the cultured cells.
Each cell culture assay was reproduced at least 3 times in
independent experiments using cells isolated from separate
women.
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Flow cytometry analysis of leukocyte subtypes
Single-cell suspensions of follicular and blood CD45-positive
cells were obtained from FF or the peripheral blood of 5
women on the day of oocyte retrieval. Cell viability was
assessed with the fixable viability stain 780 (FVS780). The
anti-human antibodies used for surface staining of leukocytes
are detailed in the supplemental data (Table S2). Cells were
stained for 30 min at 4 °C. All antibodies and FVS780 were
purchased from BD Biosciences (Franklin Lakes, NJ, USA).
The BD LSRFORTESSA cell analyzer and the BD FACS
Diva software version 8.0 (BD Biosciences) were used to
perform flow cytometry. Flow cytometry standard files (FCS
files) were further analyzed using FLOWJO version 10 soft-
ware. The gating strategy used to determine the leukocyte
subtypes is shown in the supplemental data (Fig. S1).
ELISAs for the quantification of secreted G-CSF, GROα,
MCP-1, and IL-6 and multianalyte ELISArray kits
for the qualitative evaluation of secreted human
cytokines and chemokines
Conditioned media from cultured cells were centrifuged at
15,000g for 5 min and supernatants were frozen at − 80 °C.
The concentrations of G-CSF, growth-regulated oncogene al-
pha (GROα), monocyte chemoattractant protein-1 (MCP-1),
and interleukin 6 (IL-6) were evaluated using specific ELISA
assays for G-CSF, GROα, MCP-1 (Duo Set ELISA, R&D
Systems, Minneapolis, MN, USA) and IL-6 (Human IL-6
CytoSet, Invitrogen), following the manufacturers’ protocols.
The secreted levels of IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, IL-
13, IL-17A, IFNγ, TNFα, G-CSF, and TGF-β1 and of IL-8,
MCP-1, RANTES, MIP-1α, MIP-1β, IP-10, I-TAC, MIG,
Eotaxin, TARC, MDC, and GROα were qualitatively
assessed with the human Th1/Th2/Th17 cytokines and the
human common chemokines multianalyte ELISArray kits, re-
spectively (Qiagen, Hilden, Germany). The quantificationwas
performed in duplicate for each analyzed culture medium.
Real-time PCR for mRNA quantification
Total RNAwas extracted using the High Pure RNA Isolation
Kit (Roche Life Science, Basel, Switzerland), following the
manufacturer’s protocol. Then, 200 nanograms of RNA was
reverse transcribed into cDNA using the Transcriptor First
Strand cDNA Synthesis Kit (Roche Life Science). Real-time
quantitative PCR was performed using specific primers and
Brilliant SYBR GREEN QPCR master mix (Roche Life
Science) for the 3 housekeeping genes (B2M, RPL13A, and
TBP) or the probe 43 for hG-CSF from the Universal Probe
Library (Roche Life Science) on a LightCycler® 480 (Roche




AGA-3′ and reverse 5′-TTGAGGACCTCTGTGTATTT
GTCAA-3′; TBP forward 5′-TGCACAGGAGCCAA
GAGTGAA-3′ and reverse 5′-CACATCACAGCTCC
CCACCA-3 ′ ; a n d hG -CSF f o rwa r d 5 ′ - CACC
TACAAGCTGTGCCACC-3 ′ and reverse 5 ′-TTCC
CAGTTCTTCCATCTGCT-3′. Gene expression values were
normalized to the geometric mean of the three housekeeping
genes, and mRNA expression levels were quantified using the
ΔCT method [27].
Statistical analysis
All quantitative variables followed a non-normal distribution
and are expressed as the medians ± interquartile ranges (P25–
P75) of at least three independent experiments. Statistical
analyses were conducted with GraphPad Prism software ver-
sion 5.0c (La Jolla, CA, USA). The Mann–Whitney test was
used for comparisons between two groups, while the Kruskal–
Wallis test was used for comparisons between three or more
groups. TheWilcoxon matched-pair signed rank test was used
for the comparison of leukocyte subtypes between FF and
blood. A P value < 0.05 was considered to be significant.
Results
Cocultures of granulosa cells and leukocytes enhance
G-CSF secretion
G-CSF protein, as detected by ELISA assay, was secreted by
CD45-negative hGC and fCD45 leukocytes isolated from the
FF of women undergoing IVF and by the human granulosa-
derived cell line HGL5 after 48 h of culture (Fig. 2a–d).
Secreted G-CSF protein was not detected in the 48 h leukocyte
cultures (bCD45) of cells from the peripheral blood of 7 out of
8 women undergoing IVF (Fig. 2c and d). The algebraic sum
of the amount of G-CSF secreted by 5 × 105 separately cul-
tured HGL5 cells (or hGC) and fCD45 cells (HGL5 + fCD45
or hGC + fCD45) was compared to the amount of G-CSF
secreted by the same number of cocultured cells
(HGL5/fCD45 or hGC/fCD45). There was a 20-fold increase
in the amount of secreted G-CSF when HGL5 cells were
cocultured with fCD45 cells (median = 8041 pg/ml for
HGL5/fCD45 versus 391.3 pg/ml for HGL5 + fCD45,
P= 0.008, n = 5) (Fig. 2a), and the level of secreted G-CSF
doubled when hGC and fCD45 cells were cocultured (medi-
an = 460.0 pg/ml for hGC/fCD45 versus 208.7 pg/ml for
hGC + fCD45, P = 0.04, n = 8) (Fig. 2b).
The level of secreted G-CSF was also increased 9-fold when
HGL5 cells and fCD45 cells were cocultured in physically
separated chambers but with common medium (median =
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3622 pg/ml for HGL5(fCD45) versus 391.3 pg/ml for HGL5 +
fCD45, P = 0.02, n = 5), while there was a smaller numerical,
but non-statistically significant, increase of 1.9-fold with hGC
cells (median = 404.5 pg/ml for hGC(fCD45) versus 208.7 pg/
ml for hGC + fCD45, P = 0.097, n = 3) (Fig. 2a and b).
To assess whether peripheral bCD45 cells have the same
ability to enhance G-CSF secretion as fCD45 cells, both
bCD45 and fCD45 cells were simultaneously obtained at the
time of oocyte retrieval. After 48 h of coculture, G-CSF pro-
tein was secreted by isolated HGL5 and fCD45 cells (me-
dians = 284.6 and 221.7 pg/ml, respectively), but not by
bCD45 cells. The algebraic sum of G-CSF secreted by 5 ×
105 separately cultured HGL5 and fCD45 (or bCD45) cells
(HGL5 + fCD45 or HGL5 + bCD45) was compared to the
amount of G-CSF secreted by the same number of cocultured
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significantly increased in both cocultures (median = 7637 pg/
ml for HGL5/fCD45 versus 585.5 pg/ml for HGL5 + fCD45,
P = 0.002 and 1978 pg/ml for HGL5/bCD45 versus 284.6 pg/
ml for HGL5 + bCD45, P = 0.004, n = 6), but the increase in
G-CSF secretion was higher in cocultures of HGL5 cells with
fCD45 cells than with bCD45 cells (P = 0.004) (Fig. 2c).
Similar trends were also obtained when G-CSF secretion
was evaluated in cocultures of hGC and fCD45 or bCD45
cells isolated from 3 women undergoing IVF (Fig. 2d). The
decreased stimulation achieved in cocultures of granulosa
cells with peripheral blood leukocytes compared to that
achieved in cocultures with follicular leukocytes indicates that
follicular leukocytes have a higher capacity to enhance G-CSF
production by granulosa cells.
In order to assess whether there was a transcriptional regu-
lation of G-CSF secretion, G-CSF mRNA expression was
evaluated in separate cultures of HGL5, fCD45, and bCD45
cells and in cocultures of HGL5 with fCD45 or bC45 cells. G-
CSF mRNAwas expressed by HGL5 cells, fCD45 cells, and
bCD45 cells from 4 out of 6 women, where it represented only
2 to 7% of the G-CSF mRNA isolated from fCD45 cells of the
same women. As for G-CSF protein secretion, G-CSF mRNA
expression was significantly increased in cocultures of HGL5
and fCD45 or bCD45 cells, and the increase in G-CSF mRNA
expression was higher in cocultures of HGL5 with fCD45
cells than with bCD45 cells (Fig. 2e).
Comparison of leukocyte subtypes in the FF
and peripheral blood samples of women undergoing
IVF
FACS analyses were conducted to compare leukocyte sub-
types isolated from FF or the peripheral blood of 5 women
at the time of oocyte retrieval. The gating strategy is depicted
in Fig. S1 (Supplemental data). The percentage of
granulocytes was significantly increased in follicular leuko-
cytes (Fig. 3a, median = 69.4 versus 10.0%, P = 0.03), where-
as the percentages of CD4 and CD8 T lymphocytes were
significantly decreased in the population of follicular leuko-
cytes (Fig. 3b, median = 15.0 versus 40.8%, P = 0.03 for CD4
cells and median = 4.1 versus 18.3%, P = 0.03 for CD8 cells).
Fig. 2 Cocultures of granulosa cells and leukocytes enhance G-CSF se-
cretion. G-CSF secretion (a, b, c, and d) and normalized G-CSF mRNA
levels (e) in 48 h separate cultures, cocultures, and cocultures without cell
contact of granulosa cells and leukocytes. HGL5 cells correspond to a
human granulosa-derived cell line. hGC and fCD45 cells represent hu-
man granulosa cells and leukocytes isolated from FF of women undergo-
ing IVF, while bCD45 cells represent leukocytes obtained from the pe-
ripheral blood of the same women. In each experiment, hGC were
cocultured with fCD45 or bCD45 cells isolated from the same woman.
HGL5 + fCD45, HGL5 + bCD45, hGC + fCD45, and hGC + bCD45 rep-
resent the algebraic sum of G-CSF secreted by 5 × 105 HGL5 or hGC
cells and 5 × 105 fCD45 or bCD45 cells cultured separately.
HGL5/fCD45, HGL5/bCD45, hGC/fCD45, and hGC/bCD45 represent
cocultures of 5 × 105 HGL5 or hGC cells with 5 × 105 fCD45 or bCD45
cells. HGL5(fCD45) and hGC(fCD45) represent cocultures of 5 × 105
HGL5 or hGC cells with 5 × 105 fCD45 cells without cell contact, which
were performed using plate inserts; granulosa cells were seeded into the
bottom chamber and fCD45 cells were seeded into the upper chamber.
The results are presented as scatter dot plots. Each symbol represents an
independent experiment (n = 5 (a); n = 8 (b); n = 6 (c and e) and n = 3
(d)). The central line indicates the median (50th percentile); the lower and
upper bars indicate the 25th and 75th percentiles, respectively. * P < 0.05









































































Fig. 3 Comparison of leukocyte
subtypes in the FF and peripheral
blood samples of women
undergoing IVF. The percentages
of leukocyte subtypes in the total
leukocyte population (CD45-
positive cells) are shown in fol-
licular fluid (white symbols) and
in peripheral blood (black
symbols) samples (n = 5). The re-
sults are presented as scatter dot
plots, with the horizontal line
showing the median. (a)
Monocytes, granulocytes, and B
lymphocytes. (b) CD4 T lym-
phocytes, CD8 T lymphocytes,
and NK cells. (c) CD25-positive
CD4 T lymphocytes, CD8 T
lymphocytes, and NK cells. *
P < 0.05
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The percentage of activated CD25 CD8 T lymphocytes was
also decreased in follicular leukocyte samples (Fig. 3c, medi-
an = 1.5 versus 4.3%, P = 0.03). The proportions of natural
killers (NK) cells, B lymphocytes, and monocytes in the pop-
ulations of blood and follicular leukocytes were similar.
Granulosa cells are the main source of G-CSF
HGL5 cells and follicular leukocytes (fCD45) were indi-
vidually treated overnight with monensin to inhibit pro-
tein transport and hence, G-CSF secretion in the culture
media. After monensin removal, HGL5 and fCD45 cells
were washed and cocultured for an additional 8 h. The
inhibition of G-CSF secretion after overnight exposure
to monensin was confirmed by ELISA (data not shown).
This experiment was performed with fCD45 (and not
bCD45) cells, since bCD45 cells produce far less G-CSF
than fCD45 cells (Fig. 2c and d) and thus do not allow the
detection of secreted G-CSF in short coculture experi-
ments of 8 h. When both cell types were pretreated with
monensin, G-CSF secretion decreased in the treated cells
compared with that in the untreated control cocultured
cells (median = 127.4 pg/ml for HGL5+/fCD45+ versus
430.3 pg/ml for HGL5−/fCD45−, P = 0.05) (Fig. 4a). In
cocultures of monensin-pretreated HGL5 cells and un-
treated control fCD45 cells, the level of G-CSF secretion
was similar to that of cocultures when both cell types
were pretreated with monensin (median = 150.3 pg/ml
for HGL5+/fCD45− versus 127.4 pg/ml for HGL5+/
fCD45+, P = 0.35). However, in cocultures of untreated
control HGL5 cells and monensin-pretreated fCD45 cells,
the G-CSF levels were similar to those of the untreated
control cocultures (median = 386.6 pg/ml for HGL5
−/fCD45+ versus 430.3 pg/ml for HGL5−/fCD45−, P =
0.2).
Since G-CSF secretion is also enhanced in cocultures of
HGL5 and bCD45 cells isolated from women at the time of
oocyte retrieval, we next performed coculture experiments
with bCD45 cells isolated from women with spontaneous
ovulatory cycles. Cocultures were performed for 24 h with
the following proportions of each cell type: HGL5 cells,
25% and bCD45 cells, 75%; HGL5 cells, 50% and bCD45
cells, 50%; or HGL5 cells 75% and bCD45 cells, 25%. G-CSF
secretion and mRNA expression by bCD45 cells were below
the detection limits. Both the mRNA and secreted protein
levels of G-CSF significantly increased as the percentage of
HGL5 cells increased in the coculture (Fig. 4b and c).
We also performed immunohistochemical staining of G-CSF
in human ovarian tissue. G-CSF staining was mainly localized to
the granulosa cells of secondary, preantral and antral follicles in
ovarian cortex fragments. The oocytes were also positive for G-
CSF staining (supplemental material and Fig. S2).
Altogether, these results suggest that granulosa cells are the
main source of G-CSF secretion and that CD45 cells in cocul-
tures stimulate G-CSF secretion by granulosa cells.
Effect of the menstrual cycle phase on the expression
level of G-CSF
To determine the possible effect of the menstrual cycle phase
on G-CSF expression, HGL5 cells were cultured in the pres-
ence of peripheral blood leukocytes isolated from 3 women
during the follicular, late follicular, ovulatory, or luteal phases
of one menstrual cycle. The menstrual cycle phase was deter-
mined based on the serum levels of estradiol, LH and proges-
terone (Table S1). The induction of G-CSF secreted protein
and mRNA in cocultures of HGL5 and bCD45 cells is shown
throughout one menstrual cycle for each woman (Fig. 5a–c).
In the cocultures, the induction of G-CSF secreted protein and
mRNA was significantly higher in the late follicular (LF)
phase, than in the follicular (F) or luteal (L) phase of the
menstrual cycle for the 3 women (G-CSF secreted protein:
median = 3.5-fold for LF versus 1.4-fold for F, P = 0.03; me-
dian = 3.5-fold for LF versus 1.6-fold for L, P = 0.01, Fig. 5d
and G-CSF mRNA: median = 5.0-fold for LF versus 2.1-fold
for F, P = 0.03; median = 5.0-fold for LF versus 1.8-fold for L,
P = 0.01, Fig. 5e).
The paracrine stimulation of G-CSF secretion
by leukocytes is specific
The levels of G-CSF, GROα, IL-6, MCP-1, TNFα, MIP-1α,
MIP-1β, MDC, IL-8, and TGF-β1 were measured in the con-
ditioned media of HGL5 and fCD45 cells, cocultures of
HGL5 and fCD45 cells or FFDC cells from 7 women under-
going IVF (Table S3). The other 14 cytokines/chemokines
tested were not detected in any of the conditioned media.
Only GROα, IL-6, and MCP-1 were secreted by HGL5
cells, fCD45 cells, and FFDC cells, and their levels were up-
regulated in cocultures of HGL5 and fCD45 cells. These re-
sults were confirmed by specific quantitative ELISA for these
3 cytokines/chemokines and G-CSF. Their secretion was in-
creased in cocultures of HGL5 and fCD45 cells compared
with separate cultures of HGL5 and fCD45 (P = 0.006, n =
7) (Fig. S3a). The levels of secreted G-CSF and GROα were
significantly higher in FFDC than in hGC and fCD45 cells
cultured separately (P = 0.03, n = 4) (Fig. S3b). The propor-
tions of CD45-negative hGC and CD45-positive fCD45cells
in the in FFDC population were 70/30, 54/46, 49/51, and 77/
23 for the 4 women undergoing IVF (median = 62/38).
In summary, of the 24 chemokines/cytokines tested, only
G-CSF and GROα were modulated by paracrine interactions
between follicular leukocytes and human granulosa cells,
confirming the specificity of such interactions.
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Discussion
Follicular G-CSF is predictive of oocyte competence and em-
bryo implantation potential in clinical settings [28]. However,
its role in oocyte maturation remains poorly understood.
Makinoda et al. suggested that follicular G-CSF could induce
leukocyte accumulation and activation in the pre-ovulatory
follicle and could thus be essential for successful ovulation
[29]. In this study, we evaluated the cells and mechanisms
regulating G-CSF production in developing follicles.
G-CSF secretion was significantly increased in cocultures
of follicular leukocytes with human granulosa cells or with the
HGL5 granulosa cell line compared with that in separate cell
cultures (Fig. 2a and b). The persistent but lower increase in
G-CSF secretion when cocultured cells were physically sepa-
rated by an insert indicates that direct cell-cell contacts and
soluble factors or exosomes could be involved in the paracrine
regulation of G-CSF secretion [30, 31]. Polec et al. previously
found that the secretion of angiogenic factors was increased in
cocultures of granulosa cells with monocytes isolated from the
blood of women undergoing IVF [32].
G-CSF secretion was also enhanced when hGC or the HGL5
granulosa cell line were cocultured with blood leukocytes,
confirming the specific role of leukocytes in the increase in G-
CSF secretion. However, G-CSF production was significantly
lower when granulosa cells were cocultured with blood
leucocytes than when they were cocultured with follicular
leucocytes isolated from the same woman at the time of oocyte
retrieval. The considerably higher percentage of granulocytes
(70%) isolated from FF than from the peripheral blood (10%)
of the samewoman at the time of oocyte retrieval (Fig. 3a) might
be responsible for the increased stimulation ofG-CSF production
in cocultures of granulosa cells and follicular leukocytes versus
that in cocultures of granulosa cells and peripheral blood leuko-
cytes (Fig. 2c and d). Our results support previous observations
that leukocyte populations in both types of biological fluid are
distinct [33–35]. Since neutrophils are the most abundant type of























































































































Fig. 4 Granulosa cells are the main source of G-CSF. (a) G-CSF secre-
tion in cocultures of HGL5 and fCD45 cells after exposure to monensin.
HGL5 cells correspond to a human granulosa-derived cell line, and
fCD45 cells represent leukocytes isolated from FF of women undergoing
IVF. HGL5 and fCD45 cells were individually exposed to monensin
overnight. Then, the media were removed and 4 cocultures of HGL5
and fCD45 cells were incubated for 8 h: untreated control coculture with
no previous exposure to monensin (HGL5−/fCD45−); coculture with
both cell types pretreated with monensin (HGL5+/fCD45+); coculture
with monensin-pretreated HGL5 cells and untreated control fCD45 cells
(HGL5+/fCD45−); and coculture of untreated control HGL5 cells and
monensin-pretreated fCD45 (HGL5−/fCD45+). (b) G-CSF secretion
and (c) normalized G-CSF mRNA levels in cocultures of HGL5 and
bCD45 cells isolated from the peripheral blood of women with sponta-
neous ovulatory cycles. HGL5 and bCD45 cells were cocultured for 24 h
with different proportions of each cell type: 2.5 × 105 HGL5 and 7.5 × 105
bCD45 cells (HGL5 25/bCD45 75); 5 × 105 HGL5 and 5 × 105 bCD45
cells (HGL5 50/bCD45 50); 7.5 × 105 HGL5 and 2.5 × 105 bCD45 cells
(HGL5 75/bCD45 25). The results are presented as scatter dot plots. Each
symbol represents an independent experiment (n = 3 (a) and n = 7 (b and
c)). The central line indicates the median (50th percentile); the lower and
upper bars indicate the 25th and 75th percentiles, respectively. **
P < 0.01 and *** P < 0.001
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specific accumulation of neutrophils in the preovulatory follicle
[22]. In a model of in vitro-perfused rat ovaries, the addition of
peripheral blood leukocytes increased ovulation [36], and a key
role for neutrophils has also been confirmed, with diminished
ovulation rates in animals depleted of neutrophils [37, 38].
Inhibition of protein secretion was performed in HGL5 cells
and/or leukocytes by means of monensin to identify the cell type
responsible for most of the G-CSF secretion. G-CSF secretion
was not altered in cocultures of untreated control granulosa cells
andmonensin-pretreated follicular leukocytes (Fig. 4a); however,
in cocultures of monensin-pretreated control granulosa cells and
untreated follicular leukocytes, G-CSF production was consider-
ably reduced, indicating that granulosa cells are the main source
of FF G-CSF. Data from cocultures with different proportions of
HGL5 cells and leukocytes confirm that granulosa cells are the
main source of FF G-CSF (Fig. 4b and c) and that paracrine
interactions between these cells stimulates its production.
Immunohistochemical staining ofG-CSFwas positive in gran-
ulosa cells (Fig. S2), as demonstrated previously in other reports
[21, 39]. In primordial follicles, granulosa cells displayed a faint
staining intensity compared with further follicular stages, suggest-
ing that G-CSF production commences during folliculogenesis.
The oocytes were also slightly positive for G-CSF staining. To
the best of our knowledge, this has not been previously described
in humans, since immunohistochemical staining was only per-
formedongranulosacells isolatedfromFForonthefollicularwalls
[21, 39]. However, Cai et al. showed that porcine granulosa cells
and oocytes expressG-CSFmRNA [40].
G-CSF secretion and mRNA expression were maximal in
cocultures of the granulosa cell line HGL5 and blood leuko-
cytes obtained at the late follicular phase, just before ovulation
(Fig. 5), further suggesting that circulating leukocytes that
move to the preovulatory follicle play a role in the mechanism
of ovulation. This finding also supports the results of Yanagi
et al., who found a 10-fold increase in the expression of G-
CSF mRNA in granulosa cells at the late follicular phase [39].
Despite the identification of multiple chemokines and cy-
tokines in the FF, the synthesis and secretion of only G-CSF
and GROα were upregulated by paracrine interactions be-
tween follicular leukocytes and human granulosa cells (Fig.
S3b). Both G-CSF and GROα are found at higher levels in FF
than in serum and are secreted by granulosa cells [19, 41, 42]
and leukocytes (G-CSF: monocytes, lymphocytes, natural
killer cells, and dendritic cells [10, 11]; GROα: monocytes,


















































































Fig. 5 Influence of the menstrual cycle phase on the expression level of
G-CSF. G-CSF secreted protein and mRNAwere quantified in the 48 h
cocultures of HGL5 and bCD45 cells isolated from the peripheral blood
of 3 women at different phases of one menstrual cycle. (a, b, and c)
Induction of G-CSF mRNA expression (squares and dotted lines) and
G-CSF secretion (dots and continuous lines) for subjects 1, 2, and 3
according to the menstrual cycle phase (F, follicular; LF, late follicular;
O, ovulation; L, luteal). The results are expressed as the fold change that
represents the ratio between the amount of secreted G-CSF (or G-CSF
mRNA) in the coculture of 5 × 105 HGL5 cells and 5 × 105 bCD45 cells
(HGL5/bCD45) and the algebraic sum of secreted G-CSF (or G-CSF
mRNA) in separate cultures of 5 × 105 HGL5 and 5 × 105 bCD45 cells
(HGL5 + bCD45): HGL5/bCD45 divided by (HGL5 + bCD45).
Induction of G-CSF secreted protein (d) and mRNA (e) in cocultures of
5 × 105 HGL5 and 5 × 105 bCD45 cells according to the menstrual cycle
phase. The results are presented as scatter dot plots. Each symbol repre-
sents an independent experiment (n = 14). The central line indicates the
median (50th percentile); the lower and upper bars indicate the 25th and
75th percentiles, respectively. * P < 0.05 and ** P < 0.01
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lymphocytes, and activated neutrophils [43]). GROα is a neu-
trophil chemoattractant [44]. G-CSF stimulates granulocyte
production, maturation, and function and can increase blood
neutrophil counts by releasing precursors from the bone mar-
row [10–12]. It was demonstrated that FF can exert a chemo-
tactic activity towards leukocytes, especially in conceptual
cycles [45, 46]. G-CSF and GROα could thus play a role in
the accumulation of neutrophils into the follicular wall before
ovulation. These cytokines could be involved in the matura-
tion of follicles leading to a successful ovulation.
The results of this study provide insights into the potential role
of G-CSF, a new biomarker of oocyte competence and embryo
implantation, in the mechanism of oocyte maturation and ovula-
tion. Follicular G-CSF production depends on the paracrine in-
teraction between granulosa cells and leukocytes before ovula-
tion. Our results support the hypothesis that leukocytes, and
namely granulocytes, are recruited in the preovulatory follicle,
interact with granulosa cells and regulate G-CSF (and GROα)
production at the time of ovulation. Altogether these results sug-
gest that follicular G-CSF production is associated with oocyte
maturation, further supporting the interest of follicular G-CSF as
a new tool for embryo selection in IVF cycles. Despite experi-
mental evidence that GROα secretion is also modulated by para-
crine interactions between granulosa cells and leukocytes, no
previous clinical study has identified this chemokine as a marker
of oocyte competence and embryo implantation.
Our study has some limitations. This is a laboratory re-
search study using an in vitro culture system to test the mech-
anisms of follicular G-CSF production on a relatively small
number of women undergoing IVF (n = 41). The increase in
G-CSF secretion in the coculture of primary human granulosa
cells and leukocytes was reproduced with a granulosa-derived
cell line. This cell line was used in further experiments
assessing the transcriptional regulation of G-CSF secretion
at the mRNA level, the cellular source of G-CSF secretion,
and the impact of the menstrual cycle phase. Due to the small
sample size, we could not investigate potential confounding
factors, such as the cause of infertility or the stimulation pro-
tocol on G-CSF secretion. However, we obtained similar re-
sults with blood leukocytes isolated from women with spon-
taneous ovulatory cycles. For ethical reasons, we could not
collect FF from fertile women with spontaneous ovulatory
cycles. Thus, both the quantification of FF G-CSF and the
paracrine interactions between follicular leukocytes and hu-
man granulosa cells (or the granulosa cell line HGL5) could
not be assessed at various stages of the menstrual cycle.
Another limitation is that we have not elucidated which leu-
kocyte subtype is responsible for the induction of G-CSF se-
cretion in cocultures with granulosa cells. We showed that
granulocytes are more abundant in the population of follicular
versus blood leukocytes, but it remains to be elucidated
whether granulocytes are responsible for the induction of fol-
licular G-CSF secretion by granulosa cells.
Conclusions
In clinical settings, increased follicular G-CSF concentrations are
associated with an increased probability of embryo implantation
and successful pregnancy. The notable rise in G-CSF at the time
of ovulation coincides with the accumulation of follicular
granulocytes, most likely neutrophils, which stimulate G-CSF
production by granulosa cells via paracrine interactions. This
mechanism seems to be specific since it is not observed with a
range of other FF cytokines and chemokines, except for GROα.
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